Ariane Medical Systems

Executive Summary

Ariane Medical Systems is a UK-based medical device company that has developed the Papillon+ system, a portable contact radiotherapy device using low-energy X-rays for targeted cancer treatment. The technology is designed for accessible tumors, including rectal, skin, and breast cancers, with the goal of improving organ preservation, reducing treatment times, and lowering healthcare costs. The Papillon technique offers a non-invasive alternative to surgery for early-stage cancers, potentially expanding access to radiotherapy in outpatient settings. With a focus on brachytherapy, Ariane aims to address the growing demand for effective, cost-efficient cancer therapies that minimize patient morbidity.

Upcoming Catalysts (preview)

• Q3 2026CE Mark Renewal or Expansion for Papillon+ System80% success
• Q4 2026Publication of Clinical Trial Results in Rectal Cancer60% success
• H2 2026Strategic Partnership with NHS Trusts for Adoption50% success